United States · Bill · S
S. 2057 (115th)
Pharmaceutical Regulation Conflict of Interest Act
Introduced
1 November 2017
Last action
—
Status
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Pharmaceutical Regulation Conflict of Interest Act This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration. The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment. The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 1 November 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 1 November 2017
Introduced in Senate
summary · EN · 1 November 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/2057
- Open data entity: https://api.congress.gov/v3/bill/115/s/2057